Found: 5
Select item for more details and to access through your institution.
Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP.
- Published in:
- British Journal of Pharmacology, 2012, v. 166, n. 6, p. 1793, doi. 10.1111/j.1476-5381.2012.01887.x
- By:
- Publication type:
- Article
Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2013, v. 40, n. 3, p. 227, doi. 10.1111/1440-1681.12055
- By:
- Publication type:
- Article
Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 726, doi. 10.3390/curroncol28010071
- By:
- Publication type:
- Article
The effect of carboxylesterase 1 ( CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 1, p. 21, doi. 10.1007/s00228-012-1315-5
- By:
- Publication type:
- Article
Acetyl-L-carnitine permeability across the bloodbrain barrier and involvement of carnitine transporter OCTN2.
- Published in:
- Biopharmaceutics & Drug Disposition, 2003, v. 24, n. 8, p. 357, doi. 10.1002/bdd.371
- By:
- Publication type:
- Article